Details for Patent: 9,668,981

Title:	Device for transdermal administration of drugs including acrylic based polymers
Abstract:	A transdermal delivery system is provided where the drug delivery rates, onset and profiles of at least one active agent are controlled by selectively manipulating the monomeric make up of an acrylic-based polymer in the transdermal drug delivery system. The drug carrier composition may be comprised of (a) one or more acrylic-based polymers having one or more different monomers selected from the group consisting of hard and soft monomers; (b) one or more silicone-based polymers; and (c) one or more active agents where the device provides a desired solubility for the active agent and controls drug delivery rates, onset and profiles of at least one active agent.
Inventor(s):	Kanios; David (Palmetto Bay, FL)
Assignee:	NOVEN PHARMACEUTICALS, INC. (Miami, FL)
Filing Date:	Apr 06, 2016
Application Number:	15/091,939
Claims:	1. A method for transdermally delivering a drug to a user in need thereof, comprising administering to the user a transdermal drug delivery system comprising a polymer composition comprising a blend of: (a) at least one acrylic-based polymer which acrylic-based polymer is polymerized with monomers that include: (i) a soft acrylic monomer having a glass transition temperature (T.sub.g) from about -70.degree. C. to about -10.degree. C. in an amount of from about 20 to about 70% by weight of the acrylic-based polymer; and (ii) a hard acrylic monomer having a glass transition temperature (T.sub.g) from about -5.degree. C. to about 120.degree. C. in an amount of from about 30 to about 80% by weight of the acrylic-based polymer; and (b) about 0.3% to about 30% by weight of the composition of one or more drugs, wherein said acrylic based polymers are not polymerized with methacrylic acid monomers. 2. The method according to claim 1, wherein the one or more drugs comprises methylphenidate. 3. The method according to claim 1, wherein the composition comprises from about 0.5% to about 15% by weight of the one or more drugs. 4. The method according to claim 1, wherein the composition comprises from about 1% to about 10% by weight of the one or more drugs. 5. The method according to claim 1, wherein the composition comprises from 0.3% to 30% by weight of the one or more drugs. 6. The method according to claim 1, wherein the soft acrylic monomer has a glass transition temperature (T.sub.g) from about -60.degree. C. to about -20.degree. C. 7. The method according to claim 1, wherein the soft acrylic monomer has a glass transition temperature (T.sub.g) from about -60.degree. C. to about -24.degree. C. 8. The method according to claim 1, wherein the soft acrylic monomer is one or more selected from the group consisting of 2-ethyl hexyl acrylate, isobutyl acrylate, ethyl acrylate, butyl acrylate, dodecyl methacrylate, 2-ethylhexyl methacrylate, 2-ethoxyethyl acrylate, isopropyl acrylate, and 2-methoxyethyl acrylate. 9. The method according to claim 1, wherein the hard acrylic monomer has a glass transition temperature (T.sub.g) from about 10.degree. C. to about 120.degree. C. 10. The method according to claim 1, wherein the hard acrylic monomer has a glass transition temperature (T.sub.g) from about 10.degree. C. to about 105.degree. C. 11. The method according to claim 1, wherein the hard acrylic monomer is one or more selected from the group consisting of methacrylate, N-butyl acrylate, acrylic acid, butyl methacrylate, ethyl methacrylate, methyl methacrylate, hexyl methacrylate, and methyl acrylate. 12. The method according to claim 1, wherein the composition further includes a rubber-based polymer. 13. The method according to claim 12, wherein the acrylic-based polymer comprises from 2 to about 95% by weight of the composition and the rubber-based polymer comprises from 4 to about 97% by weight of the composition. 14. The method according to claim 12, wherein the rubber-based polymer is one or more selected from the group consisting of natural and synthetic polyisoprene, polybutylene, polyisobutylene, styrene based polymers, styrene block copolymers, butadiene based polymers, styrene/butadiene polymers, styrene-isoprene-styrene block copolymers, hydrocarbon polymers, and halogen-containing polymers. 15. The method according to claim 12, wherein the wherein the rubber-based polymer includes polyisobutylene. 16. The method according to claim 1, wherein the composition further includes a silicon-based polymer. 17. The method according to claim 16, wherein the acrylic-based polymer comprises from 2 to about 95% by weight of the composition and the silicon-based polymer comprises from 4 to about 97% by weight of the composition. 18. The method according to claim 16, wherein the silicon-based polymer includes a polysiloxane polymer.